EVOLUTION OF IMMUNE RECOGNITION AND EVASION
免疫识别和逃避的进化
基本信息
- 批准号:2518794
- 负责人:
- 金额:$ 6.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-30 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:Neisseria gonorrhoeae T cell receptor Trypanosoma alleles antibody receptor bacterial antigens biochemical evolution complement computer assisted sequence analysis genetic polymorphism genetic recombination host organism interaction human immunodeficiency virus integrins major histocompatibility complex membrane transport proteins microorganism immunology natural selections nucleic acid sequence parasitism protozoal antigen statistics /biometry surface antigens virus antigen
项目摘要
The vertebrate immune system includes numerous interacting proteins
involved in the recognition and elimination of parasitic organisms. The
general goal of this research is to understand the evolution of key
molecular components of this system, particularly the molecules encoded
by the major histocompatibility complex (MHC), and to understand how
immunogenic proteins of parasitic organisms have evolved under natural
selection exerted by the host's immune system. The MHC is a multi-gene
gamily encoding cell-surface glycoproteins which play an important role
in the immune system, binding foreign peptides and presenting them to T
cells, thereby triggering an appropriate immune response. Certain MHC
loci are highly polymorphic in humans and other vertebrates, and recent
analyses of DNA sequence data have provided evidence that this
polymorphism is maintained by positive selection favoring the ability to
bind and present a variety of foreign peptides. Therefore the MHC
provides an excellent system for studying the evolution of immune
recognition and the role of infectious disease as an agent of natural
selection. The methods will involve statistical analysis of published
DNA sequences, of which there are a large number now available for MHC
genes of several mammalian species; for other immune system genes; and
for genes of parasites encoding immunogenic proteins. The purpose of
these analyses will be as follows: (10 to test the hypothesis that
polymorphism at MHC loci is maintained by overdominant selection relating
to disease resistance and to understand the role of recombination in
generating new MHC alleles; (2) to test the hypothesis that the
vertebrate immune system has exerted selection on proteins of parasitic
organisms to evade recognition by the host; and (30 to understand the
evolutionary history and patterns of co-evolution of MHC genes and other
genes playing important roles in the immune system (including T cell
receptors, integrins, Fc receptors, the C3/C4/C5 complement component
family, and the ABC family of transmembrane transporters).
GRANTS=R01HL51630
Alveolar Macrophages (AM) are the first line of cellular defense against
inhaled infectious agents such as MTB. Yet almost nothing is known about
the capacity of AM from healthy or TB patients to ingest and inhibit the
growth of MTB. Our preliminary data indicate that the effector function
of AM for avirulent MTB exceeds that of blood monocytes (MN), in part
because of increased release of tumor necrosis factor-alpha (TNF) which
serves as a macrophage activating factor (MAF). By contrast, AM are weak
producers of transforming growth factor beta (TGFbeta), a deactivating
cytokine. Mononuclear phagocytes in tuberculous granulomas, however,
express TGFbeta, as do MN from TB patients. AM from healthy subjects are
primed for effector function against MTB, but TB may be associated with
release of deactivating cytokines such as TGFbeta. AM from healthy
subjects nonspecifically suppress T lymphocyte responses to antigenic and
mitogenic and mitogenic stimuli. During TB, MN specifically suppress T
cell responses to tuberculin purified protein derivative (PPD) possibly
through increased TGFbeta which is immunosuppressive. Also during TB,
peripheral blood mononuclear cells (PBMC) are nonresponsive to the
secreted 30 Kd antigen (alphaag) of MTB; as the alphaag is a direct
stimulus for cytokine production by MN, this unresponsiveness may be due
to cytokine-induced suppression by MN. These considerations lead us to
the hypothesis that in TB, AM are specifically suppressive of T cell
responses to PPD (and the alphaag) and deactivated for killing of the
organism through increased expression of cytokines such as TGFbeta.
Together, and separately, immunosuppression and decreased effector
function contribute to the pathogenesis of TB in the lung. TB afflicts
HIV-infected persons early in their course while tuberculin skin tests
are still positive and CD4 counts relatively intact suggesting that
disturbances in effector function against MTB may be operant. We
hypothesize that these AM are defective in killing of MTB due to
increased expression of deactivating cytokines which override MAFs. Th1-
type cytokines are protective in certain animal models. We hypothesize
that in TB granulomas, macrophages express deactivating cytokines such
as TGFbeta and T cells fail to optimally express a Thi-type pattern of
cytokines. In TB granulomas from HIV=-infected persons, the cellular
architecture is distorted with a further decrease in Th1-type cytokines
produced by T cells; concurrent production of deactivating cytokines by
mononuclear phagocytes leads to an inexorable increase in load of AFB
within granulomas. The Specific Aims to test these hypotheses are: 1.
To examine the immunosuppressive activity and mediators of suppression
of AM from patients with pulmonary TB for blood T cell responses to
tuberculin PPD and the alphaag; and to compare alveolar and blood
lymphocyte responsiveness to these stimuli including production of Th1
and Th2 cytokines, and their respective cytotoxicity for antigen-pulsed
and MTB-infected AM. 2. To assess the intracellular growth of virulent
MTB in AM from patients with TB; their production of and response to
macrophage activating and deactivating cytokines; and the modulatory
effects of HIV infection. 3. To characterize the cellular architecture
and the pattern of cytokine expression in pulmonary granulomas from
patients with TB with or without HIV using the complementary approaches
of immunofluorescence. RNA PCR, in situ hybridization, and
immunohistochemistry.
脊椎动物免疫系统包括许多相互作用的蛋白
参与了寄生生物的识别和消除。 这
这项研究的一般目标是了解密钥的演变
该系统的分子成分,尤其是编码的分子
由主要的组织相容性复合物(MHC),并了解
寄生生物的免疫原性蛋白在天然下进化
宿主的免疫系统采取的选择。 MHC是多基因
游戏编码在重要作用的细胞表面糖蛋白
在免疫系统中,将外肽结合并将其呈现给T
细胞,从而触发适当的免疫反应。 某些MHC
基因座在人类和其他脊椎动物中是高度多态的,最近
DNA序列数据的分析提供了证据表明
通过积极的选择有利于能力的能力来维持多态性
结合并呈现各种外肽。 因此MHC
提供了研究免疫进化的绝佳系统
识别和传染病作为自然毒剂的作用
选择。 该方法将涉及已发布的统计分析
DNA序列,其中有大量的MHC可用
几种哺乳动物物种的基因;用于其他免疫系统基因;和
用于编码免疫原性蛋白的寄生虫基因。 目的
这些分析将如下:(10检验以下假设:
MHC基因座的多态性通过相关的过度选择来维持
抗病性并了解重组的作用
生成新的MHC等位基因; (2)检验以下假设
脊椎动物免疫系统已在寄生的蛋白质上进行选择
有机体逃避宿主的认可; (30了解
MHC基因和其他共同进化的进化史和模式
基因在免疫系统中起重要作用(包括T细胞
受体,整合素,FC受体,C3/C4/C5补体组件
家族和ABC跨膜转运蛋白家族)。
赠款= R01HL51630
肺泡巨噬细胞(AM)是针对的细胞防御
吸入感染剂,例如MTB。 但是几乎一无所知
从健康或结核病患者摄入并抑制AM的能力
MTB的生长。 我们的初步数据表明效应子功能
AM的无毒MTB超过血液单核细胞(MN)的部分
由于肿瘤坏死因子-Alpha(TNF)的释放增加了
用作巨噬细胞激活因子(MAF)。 相比之下,AM很弱
转化生长因子β(TGFBETA)的生产商,一种停用
细胞因子。 然而,结核性肉芽肿的单核吞噬细胞
表达TGFBETA,TB患者的MN也是如此。 来自健康的受试者是
针对MTB进行效应函数启动,但TB可能与
释放失活细胞因子,例如TGFBETA。 来自健康
受试者非特异性抑制对抗原和抗原的T淋巴细胞反应
有丝分裂和有丝分裂刺激。 在结核病期间,MN专门抑制T
细胞对结核蛋白纯化蛋白衍生物(PPD)的反应可能
通过增加免疫抑制的TGFBETA。 同样在结核病期间
外周血单核细胞(PBMC)对
MTB的分泌30 kd抗原(Alphaag);因为alphaag是直接的
MN生产细胞因子的刺激,这种无反应性可能应到期
通过Mn诱导细胞因子诱导的抑制。 这些考虑使我们进入
TB中AM特别抑制T细胞的假设
对PPD(和alphaag)的反应,并停用杀害
通过增加TGFBETA等细胞因子表达的生物体。
一起,分别,免疫抑制和降低效应子
功能有助于肺中结核病的发病机理。 结核病折磨
结核蛋白皮肤测试的早期艾滋病毒感染者
仍然是积极的,CD4计数相对完整,表明
针对MTB的效应函数的干扰可能是操作者。 我们
假设这些AM由于
覆盖MAF的失活细胞因子的表达增加。 th1-
类型的细胞因子在某些动物模型中具有保护性。 我们假设
在结核病肉芽肿中,巨噬细胞表达失活细胞因子这样
由于TGFBETA和T细胞无法最佳地表达
细胞因子。 在来自HIV =感染者的结核病肉芽肿中,细胞
架构被扭曲,Th1型细胞因子进一步降低
由T细胞产生;同时产生失活细胞因子
单核吞噬细胞导致AFB负载无法增加
在颗粒中。 检验这些假设的具体目的是:1。
检查免疫抑制活性和抑制介质
肺结核患者的AM用于血液T细胞的反应
结核蛋白PPD和αAg;并比较牙槽和血液
淋巴细胞对这些刺激的反应性,包括产生Th1
和Th2细胞因子及其各自的抗原粉末细胞毒性
和MTB感染的AM。 2。评估有毒的细胞内生长
TB患者的AM中的MTB;他们的产生和对
巨噬细胞激活和失活细胞因子;和调节
艾滋病毒感染的影响。 3。表征蜂窝结构
以及肺肉芽肿的细胞因子表达的模式
使用互补方法有或没有HIV的结核病患者
免疫荧光。 RNA PCR,原位杂交和
免疫组织化学。
项目成果
期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Natural selection and the evolutionary history of major histocompatibility complex loci.
- DOI:10.2741/a298
- 发表时间:1998-05
- 期刊:
- 影响因子:0
- 作者:A. Hughes;M. Yeager
- 通讯作者:A. Hughes;M. Yeager
Molecular phylogenetic evidence of cytotoxic T lymphocyte (CTL) selection on human immunodeficiency virus type 1 (HIV-1)
人类免疫缺陷病毒 1 型 (HIV-1) 细胞毒性 T 淋巴细胞 (CTL) 选择的分子系统发育证据
- DOI:10.1093/oxfordjournals.molbev.a026053
- 发表时间:1999
- 期刊:
- 影响因子:10.7
- 作者:daSilva,J;Hughes,AL
- 通讯作者:Hughes,AL
Evolution of the ATP-binding-cassette transmembrane transporters of vertebrates.
脊椎动物 ATP 结合盒跨膜转运蛋白的进化。
- DOI:10.1093/oxfordjournals.molbev.a040163
- 发表时间:1994
- 期刊:
- 影响因子:10.7
- 作者:Hughes,AL
- 通讯作者:Hughes,AL
Origin and evolution of HLA class I pseudogenes.
- DOI:10.1093/oxfordjournals.molbev.a040201
- 发表时间:1995-03
- 期刊:
- 影响因子:10.7
- 作者:Austin L. Hughes
- 通讯作者:Austin L. Hughes
Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1).
人类免疫缺陷病毒 1 (HIV-1) 的 gag、pol 和 env 基因的自然选择。
- DOI:10.1093/oxfordjournals.molbev.a040257
- 发表时间:1995
- 期刊:
- 影响因子:10.7
- 作者:Seibert,SA;Howell,CY;Hughes,MK;Hughes,AL
- 通讯作者:Hughes,AL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AUSTIN L. HUGHES其他文献
AUSTIN L. HUGHES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AUSTIN L. HUGHES', 18)}}的其他基金
相似国自然基金
效应记忆T细胞上CD147与LILRA2受体作用调控巨噬细胞活化介导类风湿关节炎的机制研究
- 批准号:82302032
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于深度学习的疾病特异性T细胞受体鉴定及功能验证
- 批准号:32370935
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肿瘤坏死因子受体CD137激活CD4+T细胞调控LL-37在玫瑰痤疮炎症中的作用及机制研究
- 批准号:82304056
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA环挤压对T细胞受体Tcrb位点V(D)J重排的调控
- 批准号:32300739
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孤儿核受体4A2调控T细胞重建促进双重移植移植物抗白血病效应的机制研究
- 批准号:82300242
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
整合素激活剂佐剂 DNA 疫苗对抗克氏锥虫感染
- 批准号:
10544403 - 财政年份:2022
- 资助金额:
$ 6.84万 - 项目类别:
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
整合素激活剂佐剂 DNA 疫苗对抗克氏锥虫感染
- 批准号:
10665082 - 财政年份:2022
- 资助金额:
$ 6.84万 - 项目类别:
Masters of immunology- how Toxoplasma gondii directly manipulates T cell activation
免疫学大师——弓形虫如何直接操纵T细胞活化
- 批准号:
9917938 - 财政年份:2018
- 资助金额:
$ 6.84万 - 项目类别:
Thrombocyte Regulation of Anti-Parasite Immunity
抗寄生虫免疫的血小板调节
- 批准号:
10560466 - 财政年份:2018
- 资助金额:
$ 6.84万 - 项目类别:
Thrombocyte Regulation of Anti-Parasite Immunity
抗寄生虫免疫的血小板调节
- 批准号:
10056191 - 财政年份:2018
- 资助金额:
$ 6.84万 - 项目类别: